Reducing antimicrobial resistance:: Cellulitis and erysipelas

This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.

Loading...

Taking too long?

Reload document

| Open in new tab

Download [154.39 KB]

You can read the full guideline by clicking here.

© NICE 2019 Cellulitis and erysipelas: antimicrobial prescribing. Available from the NICE website by clicking here. All rights reserved. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication. This guidance is published under the NICE-UK open content licence. You can access this licence by clicking here. The information above was correct at the time of publishing. This information is approved for use in the UK only.

Click here to read the Pharmacy in Practice Disclaimer. Click here to read your responsibility in regard to using NICE guidelines.